Armata Pharmaceuticals (ARMP) Stock Chart & Stock Price History $1.89 +0.02 (+1.07%) Closing price 04:10 PM EasternExtended Trading$1.90 +0.02 (+0.79%) As of 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartEarningsHeadlinesOwnershipSEC FilingsShort InterestBuy This Stock Armata Pharmaceuticals Stock Price Performance The Armata Pharmaceuticals (ARMP) stock chart highlights key performance trends across multiple timeframes. In the past month, the stock has increased 43.18%, reflecting recent market activity. As of the latest close, Armata Pharmaceuticals traded at $1.87 with a market cap of $67.66 million and volume of 148,913 shares. Five years ago, the stock traded at $3.07, representing a 38.44% decrease over that period. At the time, it had a market cap of $38.30 million and a volume of 9,700 shares. Receive ARMP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Armata Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+40.00%1 Month Performance+43.18%5 Year Performance-38.44% ARMP Stock Chart for Friday, May, 23, 2025 ARMP Chart by TradingView Armata Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/22/2025$2.10$1.87-10.95%$2.13$1.74148,913 shs$67.66 million05/21/2025$2.25$2.10-6.67%$2.31$2.05160,117 shs$75.98 million05/20/2025$2.37$2.25-5.06%$2.72$2.10741,705 shs$81.41 million05/19/2025$1.35$2.37+75.56%$2.69$1.1712.91 million shs$85.75 million05/16/2025$1.40$1.35-3.57%$1.43$1.324,814 shs$48.84 million05/15/2025$1.38$1.40+1.45%$1.43$1.383,103 shs$50.65 million05/14/2025$1.42$1.38-2.82%$1.45$1.381,748 shs$49.93 million05/13/2025$1.30$1.42+9.23%$1.49$1.293,598 shs$51.38 million05/12/2025$1.29$1.30+0.78%$1.40$1.306,279 shs$47.03 million05/09/2025$1.36$1.29-5.15%$1.44$1.2815,202 shs$46.67 million Get the Latest News and Ratings for ARMP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Armata Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 05/08/2025$1.37$1.36-0.73%$1.42$1.299,461 shs$49.21 million05/07/2025$1.38$1.37-0.72%$1.70$1.3610,446 shs$49.57 million05/06/2025$1.53$1.38-9.80%$1.53$1.385,680 shs$49.93 million05/05/2025$1.44$1.53+6.46%$1.69$1.3849,469 shs$55.36 million05/02/2025$1.35$1.44+6.85%$1.48$1.3615,065 shs$51.99 million05/01/2025$1.59$1.35-15.41%$1.63$1.2913,345 shs$48.66 million04/30/2025$1.53$1.59+3.91%$1.69$1.5632,874 shs$57.53 million04/29/2025$1.41$1.53+8.53%$1.60$1.329,166 shs$55.36 million04/28/2025$1.42$1.41-0.71%$1.49$1.384,005 shs$51.01 million04/25/2025$1.35$1.42+5.04%$1.42$1.384,666 shs$51.38 million04/24/2025$1.32$1.35+2.42%$1.43$1.306,556 shs$48.91 million04/23/2025$1.31$1.32+1.08%$1.40$1.259,375 shs$47.76 million04/22/2025$1.24$1.31+5.31%$1.31$1.275,496 shs$47.25 million Related Companies Ocugen Stock Chart Design Therapeutics Stock Chart CytomX Therapeutics Stock Chart Nuvectis Pharma Stock Chart Annexon Stock Chart Tiziana Life Sciences Stock Chart Y-mAbs Therapeutics Stock Chart Actuate Therapeutics Stock Chart Inventiva Stock Chart INmune Bio Stock Chart Receive ARMP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Armata Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NYSEAMERICAN:ARMP) was last updated on 5/23/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAIEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Armata Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Armata Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
